Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Moleculin Biotech, Inc. (MBRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,216 shares
@ $0.5903, valued at
$1.9k
Exercised 13,204 restricted stock units
@ $0 |
|
| 07/05/2023 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,584 shares
@ $0.5788, valued at
$2.1k
Exercised 14,717 restricted stock units
@ $0 |
|
| 05/26/2023 |
4
| Yan Joy (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.62, valued at
$9.3k
|
|
| 05/26/2023 |
4
| Cermak Elizabeth (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.62, valued at
$9.3k
|
|
| 05/26/2023 |
4
| Climaco John M (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.62, valued at
$9.3k
|
|
| 05/26/2023 |
4
| CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.62, valued at
$9.3k
|
|
| 05/26/2023 |
4
| George Robert E. (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.62, valued at
$9.3k
|
|
| 11/28/2022 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Bought 45,000 shares
@ $1.2807, valued at
$57.6k
|
|
| 11/23/2022 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Bought 22,500 shares
@ $1.1496, valued at
$25.9k
|
|
| 11/18/2022 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Bought 85,213 shares
@ $0.9695, valued at
$82.6k
Bought 24,742 shares
@ $1.0208, valued at
$25.3k
|
|
| 07/15/2022 |
4/A
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,584 shares
@ $1.47, valued at
$5.3k
Exercised 14,717 restricted stock units
@ $0 |
|
| 07/15/2022 |
4/A
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,215 shares
@ $1.68, valued at
$5.4k
Exercised 13,205 restricted stock units
@ $0 |
|
| 07/15/2022 |
4/A
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 225,000 options to buy
@ $1.49, valued at
$335.3k
Granted 225,000 restricted stock units
@ $0 |
|
| 07/13/2022 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,215 shares
@ $1.68, valued at
$5.4k
Exercised 13,205 restricted stock units
@ $0 |
|
| 07/06/2022 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,584 shares
@ $1.47, valued at
$5.3k
Exercised 14,717 restricted stock units
@ $0 |
|
| 06/22/2022 |
4
| PICKER DONALD H (Chief Science Officer) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 65,000 options to buy
@ $1.49, valued at
$96.9k
Granted 64,667 restricted stock units
@ $0 |
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 360,000 options to buy
@ $1.49, valued at
$536.4k
Granted 362,000 restricted stock units
@ $0 |
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| George Robert E. (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 23,333 options to buy
@ $1.49, valued at
$34.8k
Granted 15,000 options to buy
@ $1.49, valued at
$22.4k
|
|
| 06/22/2022 |
4
| CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 23,333 options to buy
@ $1.49, valued at
$34.8k
Granted 15,000 options to buy
@ $1.49, valued at
$22.4k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Yan Joy (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 23,333 options to buy
@ $1.49, valued at
$34.8k
Granted 15,000 options to buy
@ $1.49, valued at
$22.4k
|
|
| 06/21/2022 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 6,088 shares
@ $1.33, valued at
$8.1k
Exercised 25,000 restricted stock units
@ $0 |
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Yan Joy (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 6,667 options to buy
@ $1.38, valued at
$9.2k
|
|
| 03/02/2022 |
3
| Yan Joy (Director) has filed a Form 3 on Moleculin Biotech, Inc. |
| 07/12/2021 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,215 shares
@ $3.56, valued at
$11.4k
Exercised 13,205 restricted stock units
@ $0 |
|
| 07/06/2021 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Paid exercise price by delivering 3,584 shares
@ $3.56, valued at
$12.8k
Exercised 14,718 restricted stock units
@ $0 |
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| PICKER DONALD H (Chief Science Officer) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 62,676 options to buy
@ $3.73, valued at
$233.8k
|
|
| 06/21/2021 |
4
| KLEMP WALTER V (CEO and President) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 223,635 options to buy
@ $3.73, valued at
$834.2k
Granted 100,000 restricted stock units
@ $0 |
|
| 06/09/2021 |
4
| CANNON MICHAEL D (Director) has filed a Form 4 on Moleculin Biotech, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.95, valued at
$39.5k
|
|
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|